Elisabeth Wilhelm partner in consortium developing type 2 diabetes app

Dr. Elisabeth Wilhelm of the Faculty of Science and Engineering (RUG) is partner in a consortium receiving a EUR 1.2 million ERDF-subsidy to develop an app to guide diabetes patients to a drug-free life. Wilhelm will work on the scientific validation of all stages of the app's development and on the development of algorithms to be implemented in the application.

The project is coordinated by Diavantis, a Dutch company focused on supporting people with type 2 diabetes. Elastique Health from Emmen is also a partner in the project.

Reliable app

The app combines AI and IoT technology to analyze real-time health data and provide personalized guidance in areas such as nutrition, exercise, stress and sleep. ‘An app for health-related lifestyle interventions must be reliable and robust,’ says Wilhelm. ‘To develop the app, we need to solve several scientific challenges such as real-time analysis of incomplete data with machine learning.’

Take control

Boudewijn Baks (CEO of Diavantis) explains that the explosive growth of Type 2 Diabetes puts enormous pressure on the healthcare system: ‘With this app, we help people take control and more responsibility for their own health. This is not only good for the patient, but also crucial to keep healthcare affordable and, in particular. primary care accessible.’

About the ERDF grant

ERDF stands for “European Regional Development Fund”. The goal of this program is to stimulate innovation and support the transition to a low-carbon economy, while reducing key economic disparities between regions.

Read more

• Let’s get rid of those inconvenient food diaries for diabetes patients